Global Pharmaceuticals & Biotech Breakout Stocks

Bausch Health Companies

Market Cap: US$2.6b

Operates as a diversified specialty pharmaceutical and medical device company.

CareDx

Market Cap: US$2.5b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Alivus Life Sciences

Market Cap: ₹164.0b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Sino BiologicalInc

Market Cap: CN¥10.2b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

PYC Therapeutics

Market Cap: AU$2.0b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Replimune Group

Market Cap: US$1.0b

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.

GlaxoSmithKlineE

Market Cap: ج.م28.8b

Engages in production of pharmaceutical chemicals.

Egyptian International Pharmaceutical Industries

Market Cap: ج.م25.3b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

Morepen Laboratories

Market Cap: ₹37.9b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Agenus

Market Cap: US$350.0m

A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م14.0b

Develops, produces, and sells pharmaceutical products in Egypt.

Anika Therapeutics

Market Cap: US$277.5m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م12.6b

Engages in producing, marketing, selling, and storing pharmaceutical reagents for human and veterinary use.

AN2 Therapeutics

Market Cap: US$201.0m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Japan Tissue Engineering

Market Cap: JP¥30.6b

Engages in the regenerative medicine business in Japan.

Fredun Pharmaceuticals

Market Cap: ₹18.4b

Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.

Nyrada

Market Cap: AU$183.9m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

Yarrow Bioscience

Market Cap: US$94.1m

Operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.

Eloxx Pharmaceuticals

Market Cap: US$74.5m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.

BetterLife Pharma

Market Cap: US$39.7m

A biotechnology company, engages in the development of psychedelic-derived compounds.

Ambalal Sarabhai Enterprises

Market Cap: ₹3.3b

Manufactures, markets, and supplies pharmaceutical products in India and internationally.

EOM Pharmaceuticals Holdings

Market Cap: US$29.7m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

Quantum Cyber

Market Cap: US$28.7m

Operates as a technology company focused on cybersecurity and quantum computing solutions.

Sabaa International Company for Pharmaceutical and Chemical Industry

Market Cap: ج.م1.3b

Operates as a healthcare company in Egypt.

Medicure

Market Cap: CA$13.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Universe Pharmaceuticals

Market Cap: US$4.2m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.

American Green

Market Cap: US$1.1m

Operates as a technology company in the medical cannabis industry in the United States.

Cannabis Global

Market Cap: US$789.6k

Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.

Endonovo Therapeutics

Market Cap: US$180.8k

A biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine.

Affymax

Market Cap: US$111.7k

Does not have significant operations.

PaxMedica

Market Cap: US$88.4k

A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.

MPX International

Market Cap: US$14.4k

Operates as a cannabis company in Canada and internationally.

CardioGenics Holdings

Market Cap: US$14.3k

Engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market.

AmeriCann

Market Cap: US$2.4k

Designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States.